Category: Research

Our funded research has created a tool to help clinicians predict meningioma recurrence

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.

Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease

After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma

There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

We’re thrilled to be the first ever UK charity to partner with the US-based Center for Advancing Innovation (CAI), an organisation dubbed ‘Tinder for start-ups’. We’ll be co-funding a pioneering initiative coordinated by the CAI, called The Brain Race. This will ask researchers and inventors from across the world to submit innovative ideas aimed at defeating brain tumours.

A recent study highlights gaps in neuro-onoclogy services provided nationally

Further research needed to identify possible warning signs of a brain tumouriple subtle ‘changes’ and visit their GP at least once before being diagnosed with a brain tumour

New research shows that stopping the activity of the ACVR1 enzyme could slow tumour growth in diffuse midline gliomas (formerly known as DIPG)

Research suggests that treating people who have recurrent glioblastoma with immunotherapy before surgery, as well as afterwards, could be more effective

A new device nicknamed the “Tumor Monorail” has just received breakthrough device designation by the U.S. Food and Drug Administration (FDA)

Arshiya reports on an event she recently attended at Addenbrookes Hospital in Cambridge, held by Mr Mike Hart, a neurosurgery registrar.

Recent research has shown that sex differences impact outcomes for people diagnosed with a glioblastoma. These differences go beyond hormone influences and were found to be intrinsic to tumour cells

Research, funded by us as part of the INSTINCT programme, has found differences between aggressive atypical teratoid rhabdoid tumours (ATRTs) and other brain

Our successful Ask the Researcher event will give you the chance to hear more about how we’re moving closer to a cure

As part of our commitment to increasing survival and halving the harm of brain tumours, we have committed over £1 million to transformative research

Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours

Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX